SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-017772
Filing Date
2022-11-14
Accepted
2022-11-14 16:21:40
Documents
84
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q nrxp-20220930x10q.htm   iXBRL 10-Q 1473142
2 EX-10.1 nrxp-20220930xex10d1.htm EX-10.1 104213
3 EX-31.1 nrxp-20220930xex31d1.htm EX-31.1 15359
4 EX-31.2 nrxp-20220930xex31d2.htm EX-31.2 15423
5 EX-32.1 nrxp-20220930xex32d1.htm EX-32.1 7095
6 EX-32.2 nrxp-20220930xex32d2.htm EX-32.2 6417
7 GRAPHIC nrxp-20220930xex10d1002.jpg GRAPHIC 7383
8 GRAPHIC nrxp-20220930xex10d1001.jpg GRAPHIC 5455
  Complete submission text file 0001558370-22-017772.txt   7271790

Data Files

Seq Description Document Type Size
9 EX-101.SCH nrxp-20220930.xsd EX-101.SCH 69245
10 EX-101.CAL nrxp-20220930_cal.xml EX-101.CAL 41808
11 EX-101.DEF nrxp-20220930_def.xml EX-101.DEF 275145
12 EX-101.LAB nrxp-20220930_lab.xml EX-101.LAB 429816
13 EX-101.PRE nrxp-20220930_pre.xml EX-101.PRE 449599
78 EXTRACTED XBRL INSTANCE DOCUMENT nrxp-20220930x10q_htm.xml XML 1171489
Mailing Address 1201 ORANGE STREET SUITE 600 WILMINGTON DE 19801
Business Address 1201 ORANGE STREET SUITE 600 WILMINGTON DE 19801 484-254-6134
NRX Pharmaceuticals, Inc. (Filer) CIK: 0001719406 (see all company filings)

IRS No.: 822844431 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38302 | Film No.: 221385886
SIC: 2834 Pharmaceutical Preparations